These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 672613)

  • 1. Effect of dopaminergic blockade on the secretion of growth hormone and prolactin in man.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Metabolism; 1978 Aug; 27(8):921-6. PubMed ID: 672613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of TRH, cyproheptadine and pimozide on the growth hormone response to intramuscular glucagon.
    Hainer V; Urbánek J; Malec B; Krejcik L
    Horm Metab Res; 1981 Aug; 13(8):451-3. PubMed ID: 6799379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine in the inhibitory control of growth hormone and prolactin release by gastrin-releasing peptide.
    Kentroti S; McCann SM
    Brain Res Bull; 1996; 39(4):201-4. PubMed ID: 8963684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
    Hagen C; Andersen AN; Djursing H
    Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and prolactin secretion after metoclopramide administration (DA2 receptor blockade) in fertile women.
    Cunha-Filho JS; Gross JL; Vettori D; Dias EC; Passos EP
    Horm Metab Res; 2001 Sep; 33(9):536-9. PubMed ID: 11561213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the dopamine receptor blocking agent pimozide on the growth hormone response to arginine and exercise and on the spontaneous growth hormone fluctuations.
    Schwinn G; Schwarck H; McIntosh C; Milstrey HR; Willms B; Köbberling J
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1183-5. PubMed ID: 993322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of arginine, insulin and metoclopramide on growth hormone, prolactin and cortisol release in children.
    Ijaiya K; Roth B; Schwenk A
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):589-94. PubMed ID: 6994940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No acute effect of pimozide on the plasma GH levels in acromegaly.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):461-8. PubMed ID: 6613492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metoclopramide, domperidone and apomorphine on GH secretion in children and adolescents.
    Massara F; Tangolo D; Godano A; Goffi S; Bertagna A; Molinatti GM
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):451-5. PubMed ID: 3993312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prolactin response to metoclopramide in growth hormone deficient adolescent males.
    Cohen HN; Beastall GH; Fyffe JA; Fitzgerald V; Thomson JA
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):207-11. PubMed ID: 7002371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pimozide on levodopa-induced growth hormone release in man.
    Masala A; Delitala G; Alagna S; Devilla L
    Clin Endocrinol (Oxf); 1977 Sep; 7(3):253-6. PubMed ID: 908155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of prolactin secretion by metoclopramide in the rat.
    Carlson HE; Briggs JE; McCallum RW
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):475-8. PubMed ID: 847008
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats.
    Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD
    Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-mediated effects induced by metoclopramide simultaneously on adrenocorticotropic hormone and prolactin in patients with pituitary and/or hypothalamic disorders.
    Nishida S; Matsuki M; Horino M; Kawai Y; Tsushima K; Yoneda M; Oyama H; Ishii R
    Clin Chim Acta; 1990 Oct; 190(3):269-75. PubMed ID: 2174755
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of dopaminergic blockade on serum TSH and prolactin levels in thyrotoxicosis.
    Swart S; O'Malley BP; Vora J; Barnett DB; Rosenthal FD
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):330-5. PubMed ID: 6429989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion.
    Słowińska-Srzednicka J; Puciłowska J; Zgliczyński S
    Clin Exp Hypertens A; 1987; 9(11):1843-58. PubMed ID: 2830067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN; Tabor A
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin release in response to blockade of dopaminergic receptors and to TRH injection in developing and adult rats: role of estrogen in determining sex differences.
    Ojeda SR; Castro-Vázquez A; Jameson HE
    Endocrinology; 1977 Feb; 100(2):427-39. PubMed ID: 401731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cholinergic blockade on the growth hormone and prolactin response to insulin hypoglycaemia.
    Evans PJ; Dieguez C; Foord S; Peters JR; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):733-7. PubMed ID: 3893805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.